Kotaro Nagatsu Selected Research

64Cu- cyclam- RAFT- cyclo(arginyl- glycyl- aspartyl- phenylalanyl- lysyl)4

12/2020	Radiotheranostic Agent 64Cu-cyclam-RAFT-c(-RGDfK-)4 for Management of Peritoneal Metastasis in Ovarian Cancer.
6/2018	Uniform intratumoral distribution of radioactivity produced using two different radioagents, 64Cu-cyclam-RAFT-c(-RGDfK-)4 and 64Cu-ATSM, improves therapeutic efficacy in a small animal tumor model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kotaro Nagatsu Research Topics

Disease

13	Neoplasms (Cancer) 01/2022 - 01/2013
6	Pancreatic Neoplasms (Pancreatic Cancer) 10/2021 - 01/2013
5	Neoplasm Metastasis (Metastasis) 01/2022 - 08/2017
4	Body Weight (Weight, Body) 10/2021 - 06/2018
3	Stomach Neoplasms (Stomach Cancer) 10/2021 - 08/2017
2	Pheochromocytoma 07/2019 - 01/2018
1	Residual Neoplasm 10/2021
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 10/2021
1	Mesothelioma 01/2021
1	Malignant Mesothelioma 01/2021
1	Ovarian Neoplasms (Ovarian Cancer) 12/2020
1	Hypoxia (Hypoxemia) 12/2020
1	Hypersensitivity (Allergy) 11/2020
1	Melanoma (Melanoma, Malignant) 01/2020
1	Thrombocytopenia (Thrombopenia) 12/2018
1	Osteosarcoma (Osteogenic Sarcoma) 12/2018
1	Leukopenia 12/2018
1	Synovial Sarcoma (Synovioma) 07/2018
1	Weight Loss (Weight Reduction) 01/2018
1	Prostatic Neoplasms (Prostate Cancer) 01/2017
1	Colorectal Neoplasms (Colorectal Cancer) 01/2015
1	Carcinoma (Carcinomatosis) 01/2015

Drug/Important Bio-Agent (IBA)

4	RadiopharmaceuticalsIBA 01/2021 - 06/2018
3	Radioisotopes (Radionuclides)IBA 01/2021 - 01/2018
3	Monoclonal AntibodiesIBA 03/2015 - 01/2013
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2021
2	ErbB Receptors (EGF Receptor)IBA 10/2021 - 08/2017
2	Cetuximab (Erbitux)FDA Link 10/2021 - 10/2019
2	Therapeutic UsesIBA 01/2021 - 01/2018
2	AntibodiesIBA 01/2021 - 01/2015
2	IntegrinsIBA 12/2020 - 06/2018
2	64Cu- cyclam- RAFT- cyclo(arginyl- glycyl- aspartyl- phenylalanyl- lysyl)4IBA 12/2020 - 06/2018
2	Immunoglobulin G (IgG)IBA 07/2020 - 12/2018
2	1-(3-astatobenzyl)guanidineIBA 07/2019 - 01/2018
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	Aminocaproic Acid (6 Aminocaproic Acid)FDA LinkGeneric 01/2022
1	Red Fluorescent ProteinIBA 10/2021
1	LuciferasesIBA 10/2021
1	PolymersIBA 01/2021
1	gastric inhibitory polypeptide receptorIBA 01/2021
1	Biological ProductsIBA 01/2021
1	arseniteIBA 11/2020
1	Phosphorus (Red Phosphorus)IBA 01/2020
1	metabotropic glutamate receptor type 1IBA 01/2020
1	N-methylbenzamideIBA 01/2020
1	Oncogene Proteins (Oncogene Protein)IBA 01/2020
1	pyridineIBA 01/2020
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2020
1	micaIBA 12/2018
1	Astatine-211IBA 12/2018
1	Staphylococcal Protein A (Protein A)IBA 12/2018
1	arginyl-glycyl-aspartic acidIBA 06/2018
1	cyclic arginine-glycine-aspartic acid peptideIBA 06/2018
1	DNA (Deoxyribonucleic Acid)IBA 08/2017
1	Trastuzumab (Herceptin)FDA Link 08/2017
1	LigandsIBA 01/2017
1	SolutionsIBA 01/2017
1	cupric chloride (copper(II) chloride)FDA Link 01/2017
1	Copper-64IBA 01/2017
1	PSMA-617IBA 01/2017
1	AntigensIBA 01/2017
1	BuffersIBA 01/2017
1	Transferrin Receptors (Transferrin Receptor)IBA 03/2015

Therapy/Procedure

11	Therapeutics 10/2021 - 01/2013
3	Radioimmunotherapy 10/2021 - 10/2019
2	Radiotherapy 12/2020 - 07/2019
2	Intravenous Injections 01/2020 - 01/2018
1	Operative Surgical Procedures 10/2021
1	Computer-Assisted Surgery (Image Guided Surgery) 10/2020
1	Photothermal Therapy 01/2020
1	Molecular Targeted Therapy 03/2015